| scholarly article | Q13442814 |
| P2093 | author name string | H Wang | |
| M Chen | |||
| S B Levy | |||
| J L Dzink-Fox | |||
| P2860 | cites work | CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice | Q24286950 |
| Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 | ||
| Overexpression of the marA or soxS regulatory gene in clinical topoisomerase mutants of Escherichia coli | Q33698034 | ||
| Topoisomerase IV is a target of quinolones in Escherichia coli | Q33724600 | ||
| Positive control of a global antioxidant defense regulon activated by superoxide-generating agents in Escherichia coli | Q33741037 | ||
| Cloning and characterization of a DNA gyrase A gene from Escherichia coli that confers clinical resistance to 4-quinolones. | Q33742392 | ||
| Association between double mutation in gyrA gene of ciprofloxacin-resistant clinical isolates of Escherichia coli and MICs | Q33762110 | ||
| Antimicrobial resistance of Neisseria gonorrhoeae and high prevalence of ciprofloxacin-resistant isolates in Japan, 1993 to 1998 | Q33965267 | ||
| Impact of gyrA and parC mutations on quinolone resistance, doubling time, and supercoiling degree of Escherichia coli. | Q33976675 | ||
| Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pump | Q33978398 | ||
| Non-target gene mutations in the development of fluoroquinolone resistance in Escherichia coli | Q33979064 | ||
| AcrAB efflux pump plays a major role in the antibiotic resistance phenotype of Escherichia coli multiple-antibiotic-resistance (Mar) mutants | Q34370243 | ||
| Relationship between quinolone use and emergence of ciprofloxacin-resistant Escherichia coli in bloodstream infections | Q35111896 | ||
| Molecular epidemiology of fluoroquinolone-resistant Escherichia coli bloodstream isolates from patients admitted to European cancer centers | Q35122412 | ||
| Detection of mutations in parC in quinolone-resistant clinical isolates of Escherichia coli. | Q35122643 | ||
| Genetic evidence for a role of parC mutations in development of high-level fluoroquinolone resistance in Escherichia coli. | Q35123629 | ||
| Contributions of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals. | Q35128319 | ||
| Development of resistance to nalidixic acid and the fluoroquinolones after the introduction of norfloxacin and ofloxacin | Q35319641 | ||
| Cross-resistance to fluoroquinolones in multiple-antibiotic-resistant (Mar) Escherichia coli selected by tetracycline or chloramphenicol: decreased drug accumulation associated with membrane changes in addition to OmpF reduction | Q35343881 | ||
| Activation of multiple antibiotic resistance and binding of stress-inducible promoters by Escherichia coli Rob protein | Q35581659 | ||
| Role of the acrAB locus in organic solvent tolerance mediated by expression of marA, soxS, or robA in Escherichia coli | Q35631010 | ||
| Mutations in the gyrA gene of a highly fluoroquinolone-resistant clinical isolate of Escherichia coli | Q35811107 | ||
| Characterization of fluoroquinolone-resistant mutants of escherichia coli selected in vitro | Q35821472 | ||
| Genetic and functional analysis of the multiple antibiotic resistance (mar) locus in Escherichia coli | Q35912437 | ||
| Two divergently transcribed genes, soxR and soxS, control a superoxide response regulon of Escherichia coli | Q36145766 | ||
| marA locus causes decreased expression of OmpF porin in multiple-antibiotic-resistant (Mar) mutants of Escherichia coli | Q36223906 | ||
| Amplifiable resistance to tetracycline, chloramphenicol, and other antibiotics in Escherichia coli: involvement of a non-plasmid-determined efflux of tetracycline | Q36331626 | ||
| Overexpression of the robA gene increases organic solvent tolerance and multiple antibiotic and heavy metal ion resistance in Escherichia coli. | Q36709289 | ||
| Association with prior fluoroquinolone therapy of widespread ciprofloxacin resistance among gram-negative isolates in a Veterans Affairs medical center | Q36752823 | ||
| Differential expression of over 60 chromosomal genes in Escherichia coli by constitutive expression of MarA. | Q38311410 | ||
| High-level fluoroquinolone-resistant clinical isolates of Escherichia coli overproduce multidrug efflux protein AcrA. | Q39475770 | ||
| AcrD of Escherichia coli is an aminoglycoside efflux pump | Q39499577 | ||
| Multidrug resistance following expression of the Escherichia coli marA gene in Mycobacterium smegmatis. | Q39566356 | ||
| Detection of gyrA and gyrB mutations in quinolone-resistant clinical isolates of Escherichia coli by single-strand conformational polymorphism analysis and determination of levels of resistance conferred by two different single gyrA mutations | Q39780132 | ||
| Quinolone-resistant mutants of escherichia coli DNA topoisomerase IV parC gene | Q39781656 | ||
| gyrA and gyrB mutations in quinolone-resistant strains of Escherichia coli | Q39814986 | ||
| Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli | Q39816339 | ||
| Activation of oxidative stress genes by mutations at the soxQ/cfxB/marA locus of Escherichia coli | Q39942365 | ||
| Two complementation groups mediate tetracycline resistance determined by Tn10 | Q39984225 | ||
| 4-Quinolone resistance mutations in the DNA gyrase of Escherichia coli clinical isolates identified by using the polymerase chain reaction | Q40085967 | ||
| Quinolone resistance-determining region in the DNA gyrase gyrB gene of Escherichia coli | Q40087129 | ||
| Quinolone Mode of Action - New Aspects† | Q40489458 | ||
| Molecular characterization of the soxRS genes of Escherichia coli: two genes control a superoxide stress regulon | Q40506211 | ||
| The emergence of highly fluoroquinolone-resistant Escherichia coli in community-acquired urinary tract infections | Q44324064 | ||
| Development of resistance in Pseudomonas aeruginosa to imipenem, norfloxacin, and ciprofloxacin during therapy: proof provided by typing with a DNA probe | Q44662659 | ||
| Nalidixic acid-resistant mutations of the gyrB gene of Escherichia coli | Q46102812 | ||
| The local repressor AcrR plays a modulating role in the regulation of acrAB genes of Escherichia coli by global stress signals | Q46280464 | ||
| Quinolone-resistant mutations of the gyrA gene of Escherichia coli | Q48332361 | ||
| Association of organic solvent tolerance and fluoroquinolone resistance in clinical isolates of Escherichia coli. | Q52247046 | ||
| Mechanisms involved in the development of resistance to fluoroquinolones in Escherichia coli isolates. | Q54069730 | ||
| Construction and use of a new broad-host-range lacZ transcriptional fusion vector, pHRP309, for gram- bacteria. | Q54228474 | ||
| Rapid development of ciprofloxacin resistance in methicillin-susceptible and -resistant Staphylococcus aureus. | Q54294777 | ||
| gyrA mutations in high-level fluoroquinolone-resistant clinical isolates of Escherichia coli. | Q54581647 | ||
| Mechanisms of Resistance to Quinolones | Q72092628 | ||
| Mechanisms of fluoroquinolone resistance | Q74371163 | ||
| Molecular analysis of fluoroquinolone-resistance in Escherichia coli on the aspect of gyrase and multiple antibiotic resistance (mar) genes | Q74654645 | ||
| Analysis of the mutations involved in fluoroquinolone resistance of in vivo and in vitro mutants of Escherichia coli | Q78166633 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | People's Republic of China | Q148 |
| Escherichia coli | Q25419 | ||
| P304 | page(s) | 1515-1521 | |
| P577 | publication date | 2001-05-01 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Genetic characterization of highly fluoroquinolone-resistant clinical Escherichia coli strains from China: role of acrR mutations | |
| P478 | volume | 45 |
| Q41881440 | 'Supermutators' found amongst highly levofloxacin-resistant E. coli isolates: a rapid protocol for the detection of mutation sites |
| Q42214298 | Acceleration and suppression of resistance development by antibiotic combinations |
| Q36898391 | AcrS/EnvR represses expression of the acrAB multidrug efflux genes in Escherichia coli |
| Q34631443 | Active efflux, a common mechanism for biocide and antibiotic resistance |
| Q55225078 | Adaptive modulation of antibiotic resistance through intragenomic coevolution. |
| Q42708801 | Alteration in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in Quinolone-resistant Shigella dysenteriae serotype 1 clinical isolates from Kolkata, India |
| Q64978675 | An evaluation of multidrug-resistant Escherichia coli isolates in urinary tract infections from Aguascalientes, Mexico: cross-sectional study. |
| Q38560919 | Antibacterial properties of L-amino acid oxidase: mechanisms of action and perspectives for therapeutic applications |
| Q29620008 | Antibacterial resistance worldwide: causes, challenges and responses |
| Q43693445 | Antibiotic resistance of uropathogens isolated from Al-Shifa hospital in Gaza Strip in 2002. |
| Q39887758 | Antimicrobial biocides in the healthcare environment: efficacy, usage, policies, and perceived problems |
| Q36298715 | Antimicrobial susceptibilities of aerobic and facultative gram-negative bacilli isolated from Chinese patients with urinary tract infections between 2010 and 2014 |
| Q90257107 | Associations between sensitivity to antibiotics, disinfectants and heavy metals in natural, clinical and laboratory isolates of Escherichia coli |
| Q24613731 | Bacterial charity work leads to population-wide resistance |
| Q91063368 | Bacterial persistence promotes the evolution of antibiotic resistance by increasing survival and mutation rates |
| Q52282006 | Bacterial resistance: origins, epidemiology, and impact. |
| Q33836664 | Biological cost of single and multiple norfloxacin resistance mutations in Escherichia coli implicated in urinary tract infections. |
| Q64106427 | Changing paradigm of antibiotic resistance amongst Escherichia coli isolates in Indian pediatric population |
| Q41858474 | Characterization of RarA, a novel AraC family multidrug resistance regulator in Klebsiella pneumoniae |
| Q37157491 | Characterization of multiple-antimicrobial-resistant Escherichia coli isolates from diseased chickens and swine in China. |
| Q35879251 | Ciprofloxacin-resistant Salmonella enterica Typhimurium and Choleraesuis from pigs to humans, Taiwan |
| Q34596560 | Clinical and molecular epidemiology of Escherichia coli sequence type 131 among hospitalized patients colonized intestinally with fluoroquinolone-resistant E. coli |
| Q34838791 | Clinical importance and epidemiology of quinolone resistance |
| Q41008865 | Cloning of a novel gene for quinolone resistance from a transferable plasmid in Shigella flexneri 2b. |
| Q31156637 | Cloning, sequencing, and characterization of the SdeAB multidrug efflux pump of Serratia marcescens |
| Q39652330 | CmeABC functions as a multidrug efflux system in Campylobacter jejuni |
| Q29346558 | CmeR functions as a transcriptional repressor for the multidrug efflux pump CmeABC in Campylobacter jejuni |
| Q39157364 | Comparative study on the antibiotic susceptibility and plasmid profiles of Vibrio alginolyticus strains isolated from four Tunisian marine biotopes |
| Q58756032 | Conserved collateral antibiotic susceptibility networks in diverse clinical strains of Escherichia coli |
| Q33676174 | Constitutive SoxS expression in a fluoroquinolone-resistant strain with a truncated SoxR protein and identification of a new member of the marA-soxS-rob regulon, mdtG |
| Q44599391 | Contribution of efflux to cefuroxime resistance in clinical isolates of Escherichia coli |
| Q41883341 | Contribution of mutation at amino acid 45 of AcrR to acrB expression and ciprofloxacin resistance in clinical and veterinary Escherichia coli isolates. |
| Q36444536 | Contributions of mutations in acrR and marR genes to organic solvent tolerance in Escherichia coli |
| Q34487416 | Correlation of overexpression of efflux pump genes with antibiotic resistance in Escherichia coli Strains clinically isolated from urinary tract infection patients |
| Q41873330 | Decreased prevalence of virulence factors among ciprofloxacin-resistant uropathogenic Escherichia coli isolates. |
| Q57130068 | Detection and Characterization of Antibiotic-Resistant Bacteria Using Surface-Enhanced Raman Spectroscopy |
| Q35127793 | Duration of outpatient fecal colonization due to Escherichia coli Isolates with decreased susceptibility to fluoroquinolones: longitudinal study of patients recently discharged from the hospital |
| Q36138147 | Efflux-mediated antimicrobial resistance |
| Q35626332 | Efflux-mediated drug resistance in bacteria |
| Q33983331 | Emergence of reduced susceptibility and resistance to fluoroquinolones in Escherichia coli in Taiwan and contributions of distinct selective pressures |
| Q35023326 | Endocarditis caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: emergence of resistance to ciprofloxacin and piperacillin-tazobactam during treatment despite initial susceptibility |
| Q39195574 | Environmental and genetic modulation of the phenotypic expression of antibiotic resistance |
| Q38784666 | Epidemiology and characteristics of Escherichia coli sequence type 131 (ST131) from long-term care facility residents colonized intestinally with fluoroquinolone-resistant Escherichia coli |
| Q36845365 | European emergence of ciprofloxacin-resistant Escherichia coli clonal groups O25:H4-ST 131 and O15:K52:H1 causing community-acquired uncomplicated cystitis |
| Q62635883 | Evaluation of quinolones for use in detection of determinants of acquired quinolone resistance, including the new transmissible resistance mechanisms qnrA, qnrB, qnrS, and aac(6')Ib-cr, in Escherichia coli and Salmonella enterica and determinations o |
| Q47725174 | Fitness cost constrains the spectrum of marR mutations in ciprofloxacin-resistant Escherichia coli |
| Q46921856 | Fluoroquinolone resistance linked to both gyrA and parC mutations in the quinolone resistance-determining region of Shigella dysenteriae type 1. |
| Q36871802 | Fluoroquinolone resistance mechanisms in an Escherichia coli isolate, HUE1, without quinolone resistance-determining region mutations |
| Q43062855 | Fluoroquinolone resistance mechanisms in multidrug-resistant Escherichia coli isolated from extraintestinal infections in dogs. |
| Q33910855 | Fluoroquinolone resistance mechanisms of Shigella flexneri isolated in Bangladesh. |
| Q36660768 | Foodborne urinary tract infections: a new paradigm for antimicrobial-resistant foodborne illness |
| Q33905604 | Gastrointestinal tract colonization with fluoroquinolone-resistant Escherichia coli in hospitalized patients: changes over time in risk factors for resistance |
| Q47226881 | Genetic characterization of phenicol-resistant Escherichia coli and role of wild-type repressor/regulator gene (acrR) on phenicol resistance |
| Q28545741 | Genome Analysis of the First Extensively Drug-Resistant (XDR) Mycobacterium tuberculosis in Malaysia Provides Insights into the Genetic Basis of Its Biology and Drug Resistance |
| Q33836661 | Genomics of rapid adaptation to antibiotics: convergent evolution and scalable sequence amplification |
| Q36337074 | Global fluoroquinolone resistance epidemiology and implictions for clinical use. |
| Q36526009 | Heavy use of prophylactic antibiotics in aquaculture: a growing problem for human and animal health and for the environment |
| Q41388247 | High prevalence of plasmid-mediated quinolone resistance genes qnr and aac(6')-Ib-cr in clinical isolates of Enterobacteriaceae from nine teaching hospitals in China |
| Q79162727 | Hypermutation as a Factor Contributing to the Acquisition of Antimicrobial Resistance |
| Q40343747 | Identification of Potentially Involved Proteins in Levofloxacin Resistance Mechanisms in Coxiella burnetii |
| Q40795967 | Identification of emergent bla CMY-2 -carrying Proteus mirabilis lineages by whole-genome sequencing |
| Q52620715 | Improvement in organic solvent tolerance by double disruptions of proV and marR genes in Escherichia coli. |
| Q35758863 | Increased genome instability in Escherichia coli lon mutants: relation to emergence of multiple-antibiotic-resistant (Mar) mutants caused by insertion sequence elements and large tandem genomic amplifications |
| Q33360684 | Insights into the environmental resistance gene pool from the genome sequence of the multidrug-resistant environmental isolate Escherichia coli SMS-3-5. |
| Q37157099 | Interplay between two RND systems mediating antimicrobial resistance in Brucella suis. |
| Q34085440 | Isolation of Escherichia coli strains with AcrAB-TolC efflux pump-associated intermediate interpretation or resistance to fluoroquinolone, chloramphenicol and aminopenicillin from dogs admitted to a university veterinary hospital |
| Q35023363 | MarA-like regulator of multidrug resistance in Yersinia pestis |
| Q42234726 | Mechanisms accounting for fluoroquinolone resistance in Escherichia coli clinical isolates |
| Q38724103 | Mechanisms of fluoroquinolone resistance in Escherichia coli isolates from food-producing animals |
| Q47135657 | Mechanisms of quinolone resistance in Escherichia coli isolated from companion animals, pet-owners, and non-pet-owners |
| Q36155441 | Mechanisms of resistance to quinolones |
| Q44226761 | Modeling the role of altruism of antibiotic-resistant bacteria |
| Q35142025 | Modulation of Bacterial Multidrug Resistance Efflux Pumps of the Major Facilitator Superfamily |
| Q30385057 | Modulation of Membrane Influx and Efflux in Escherichia coli Sequence Type 131 Has an Impact on Bacterial Motility, Biofilm Formation, and Virulence in a Caenorhabditis elegans Model |
| Q37204206 | Molecular analysis of the gyrA and gyrB quinolone resistance-determining regions of fluoroquinolone-resistant Clostridium difficile mutants selected in vitro |
| Q28493026 | Molecular characterization of MexL, the transcriptional repressor of the mexJK multidrug efflux operon in Pseudomonas aeruginosa |
| Q41277605 | Multidrug resistance and plasmid patterns of Escherichia coli O157 and other E. coli Isolated from diarrhoeal stools and surface waters from some selected sources in Zaria, Nigeria |
| Q43169553 | Multidrug-resistant Salmonellae isolated in Japanese quails reared in Abeokuta, Nigeria |
| Q36048167 | Mutation rate and evolution of fluoroquinolone resistance in Escherichia coli isolates from patients with urinary tract infections. |
| Q44596874 | Patterns of mutations in target genes in septicemia isolates of Escherichia coli and Klebsiella pneumoniae with resistance or reduced susceptibility to ciprofloxacin |
| Q39131830 | Phenotypic and genotypic characterization of enteroaggregative Escherichia coli isolates from pediatric population in Pakistan |
| Q35102456 | Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China |
| Q38097417 | Plasmid-mediated quinolone resistance--current knowledge and future perspectives |
| Q42218073 | Plasmid-related quinolone resistance determinants in epidemic Vibrio parahaemolyticus, uropathogenic Escherichia coli, and marine bacteria from an aquaculture area in Chile |
| Q54210816 | Predictable Phenotypes of Antibiotic Resistance Mutations. |
| Q34454311 | Prediction of antibiotic resistance by gene expression profiles. |
| Q35854877 | Prediction of resistance development against drug combinations by collateral responses to component drugs |
| Q42155904 | Presence of multi-drug resistant pathogenic Escherichia coli in the San Pedro River located in the State of Aguascalientes, Mexico |
| Q42924494 | Putative link between the virulence-associated fluA gene and fluoroquinolone resistance in uropathogenic Escherichia coli |
| Q33830227 | Quinolone resistance in escherichia coli from Accra, Ghana |
| Q43098014 | Quorum-sensing regulator sdiA and marA overexpression is involved in in vitro-selected multidrug resistance of Escherichia coli |
| Q34068877 | Rapid evolution of fluoroquinolone-resistant Escherichia coli in Nigeria is temporally associated with fluoroquinolone use |
| Q34300836 | Regulation of bacterial drug export systems |
| Q36080164 | Resistance Pattern and Molecular Characterization of Enterotoxigenic Escherichia coli (ETEC) Strains Isolated in Bangladesh |
| Q35676448 | Resistance to antimicrobial drugs in Ghana |
| Q36683498 | Resistance-Nodulation-Division Multidrug Efflux Pumps in Gram-Negative Bacteria: Role in Virulence |
| Q54345829 | Restoration of antibiotic susceptibility in fluoroquinolone-resistant Escherichia coli by targeting acrB with antisense phosphorothioate oligonucleotide encapsulated in novel anion liposome. |
| Q36330973 | Risk factors for efflux pump overexpression in fluoroquinolone-resistant Escherichia coli |
| Q41669705 | Role for tandem duplication and lon protease in AcrAB-TolC- dependent multiple antibiotic resistance (Mar) in an Escherichia coli mutant without mutations in marRAB or acrRAB. |
| Q35685143 | Role of AcrR and ramA in fluoroquinolone resistance in clinical Klebsiella pneumoniae isolates from Singapore. |
| Q33676324 | Single nucleotide polymorphism analysis of the major tripartite multidrug efflux pump of Escherichia coli: functional conservation in disparate animal reservoirs despite exposure to antimicrobial chemotherapy |
| Q34720052 | Spread of Escherichia coli strains with high-level cefotaxime and ceftazidime resistance between the community, long-term care facilities, and hospital institutions |
| Q42880673 | Study of Organic Solvent Tolerance and Increased Antibiotic Resistance Properties in E. coli gyrA Mutants |
| Q37049823 | Temporal changes in resistance mechanisms in colonizing Escherichia coli isolates with reduced susceptibility to fluoroquinolones |
| Q91411182 | Temporal dynamics of bacteria-plasmid coevolution under antibiotic selection |
| Q34111927 | The AcrAB-TolC efflux pump contributes to multidrug resistance in the nosocomial pathogen Enterobacter aerogenes |
| Q35482558 | The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria |
| Q22065663 | The emergence of antibiotic resistance by mutation |
| Q37408471 | The epidemic of extended-spectrum-β-lactamase-producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-Rx |
| Q42659717 | The genetic basis of the fitness costs of antimicrobial resistance: a meta-analysis approach |
| Q41363141 | The global consequence of disruption of the AcrAB-TolC efflux pump in Salmonella enterica includes reduced expression of SPI-1 and other attributes required to infect the host. |
| Q28084596 | The ins and outs of RND efflux pumps in Escherichia coli |
| Q39706051 | The periplasmic protein MppA requires an additional mutated locus to repress marA expression in Escherichia coli |
| Q98157764 | The prevalence and mechanism of fluoroquinolone resistance in Escherichia coli isolated from swine farms in China |
| Q33964949 | The prevalence of fluoroquinolone resistance mechanisms in colonizing Escherichia coli isolates recovered from hospitalized patients |
| Q92015683 | Thymol tolerance in Escherichia coli induces morphological, metabolic and genetic changes |
| Q37612974 | Tigecycline Nonsusceptibility Occurs Exclusively in Fluoroquinolone-Resistant Escherichia coli Clinical Isolates, Including the Major Multidrug-Resistant Lineages O25b:H4-ST131-H30R and O1-ST648. |
| Q64102729 | Two putative MmpL homologs contribute to antimicrobial resistance and nephropathy of enterohemorrhagic O157:H7 |
| Q47709543 | Whole-genome sequencing and genetic analysis reveals novel stress responses against individual constituents of essential oils in Escherichia coli. |
| Q55215658 | Wicked: The untold story of ciprofloxacin. |
| Q35689337 | Yersinia pestis AcrAB-TolC in antibiotic resistance and virulence |
Search more.